State budget 61,3 million to personalized medicine

Funds for personalized medicine, clinical trials, mature clusters, and digitalisation – these are some of the main points for cancer innovation in the newly released state budget.

Swedish women’s health company Gedea Biotech awarded €3 M by EU’s Horizon 2020 to accelerate introduction of antibiotic-free treatment for vaginal infections

Call for national funding for cross-border life science initiatives

InDex Pharmaceuticals updates shareholders list

InDex Pharmaceuticals Holding AB (publ) today announced that the list of shareholders has been updated on the homepage with information as of August 30, 2019.

SmiLe company representatives attend Nordic investor conference

This week around 30 life science companies from southern Sweden – almost half of which are associated with SmiLe – are attending the LSX Nordic congress at NASDAQ in Stockholm.

SAGA raises 40 million SEK (€3.7 million) to advance ultrasensitive cancer liquid biopsies

‍SAGA Diagnostics AB today announces the raising of SEK 40 million in venture-backed financing (circa EUR 3.7 million, USD 4.1 million).